share_log

Arteris Insiders Benefit From Selling Stock At US$6.48

Arteris Insiders Benefit From Selling Stock At US$6.48

Arteris内部人士受益于以6.48美元的价格出售股票
Simply Wall St ·  05/04 10:10

Even though Arteris, Inc. (NASDAQ:AIP) stock gained 23% last week, insiders who sold US$235k worth of stock over the past year are probably better off. Holding on to stock would have meant their investment would be worth less now than it was at the time of sale. Thus selling at an average price of US$6.48, which is higher than the current price, may have been the best decision.

尽管上周Arteris公司(纳斯达克股票代码:AIP)的股票上涨了23%,但在过去一年中出售了价值23.5万美元股票的内部人士的境况可能更好。持有股票意味着他们现在的投资价值将低于出售时的价值。因此,以6.48美元的平均价格(高于当前价格)出售可能是最好的决定。

Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.

尽管我们认为股东不应该简单地关注内幕交易,但逻辑要求你应该注意内部人士是在买入还是卖出股票。

The Last 12 Months Of Insider Transactions At Arteris

Arteris最近 12 个月的内幕交易

In the last twelve months, the biggest single sale by an insider was when the Chairman, Karel Janac, sold US$71k worth of shares at a price of US$7.03 per share. That means that even when the share price was below the current price of US$8.21, an insider wanted to cash in some shares. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. This single sale was just 0.1% of Karel Janac's stake.

在过去的十二个月中,内部人士最大的一次出售是董事长卡雷尔·贾纳克以每股7.03美元的价格出售了价值7.1万美元的股票。这意味着,即使股价低于当前的8.21美元,内部人士也想套现一些股票。当内部人士以低于当前价格的价格出售时,这表明他们认为较低的价格是公平的。这让我们想知道他们如何看待最近(更高的)估值。尽管内幕抛售不是一个积极的信号,但我们无法确定这是否意味着内部人士认为股票已完全估值,因此这只是一个弱势信号。此次出售仅占卡雷尔·贾纳克股份的0.1%。

In the last year Arteris insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

去年,Arteris内部人士没有购买任何公司股票。你可以在下面看到过去 12 个月内幕交易(公司和个人)的直观描述。通过点击下面的图表,你可以看到每笔内幕交易的确切细节!

insider-trading-volume
NasdaqGM:AIP Insider Trading Volume May 4th 2024
纳斯达克通用汽车公司:AIP 内幕交易量 2024 年 5 月 4 日

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

对于那些喜欢寻找中奖投资的人来说,这份最近有内幕收购的成长型公司的免费名单可能只是门票。

Insiders At Arteris Have Sold Stock Recently

Arteris的内部人士最近出售了股票

The last quarter saw substantial insider selling of Arteris shares. In total, insiders dumped US$163k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.

上个季度,Arteris股票遭到大量内幕抛售。在此期间,内部人士总共抛售了价值16.3万美元的股票,我们没有记录任何购买记录。总的来说,这使我们有点谨慎,但这并不是万能的。

Insider Ownership Of Arteris

Arteris的内部所有权

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. Arteris insiders own about US$73m worth of shares. That equates to 32% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

我喜欢看看内部人士在一家公司拥有多少股票,以帮助我了解他们与内部人士的看法。我们通常希望看到相当高的内部所有权水平。Arteris内部人士拥有价值约7300万美元的股票。这相当于该公司的32%。这种内部所有权水平不错,但还没有特别突出。这无疑表明了一定程度的一致性。

So What Do The Arteris Insider Transactions Indicate?

那么,Arteris内幕交易表明了什么呢?

Insiders sold stock recently, but they haven't been buying. And even if we look at the last year, we didn't see any purchases. Insider ownership isn't particularly high, so this analysis makes us cautious about the company. We're in no rush to buy! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Arteris. Case in point: We've spotted 4 warning signs for Arteris you should be aware of.

内部人士最近出售了股票,但他们一直没有买入。而且,即使我们看看去年,我们也没有看到任何购买。内部所有权并不是特别高,因此这种分析使我们对公司持谨慎态度。我们并不急于购买!除了了解正在进行的内幕交易外,确定Arteris面临的风险也是有益的。一个很好的例子:我们发现了4个你应该注意的动脉炎警告信号。

But note: Arteris may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但请注意:Arteris可能不是最好的买入股票。因此,来看看这份投资回报率高、债务低的有趣公司的免费清单。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发